These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1783745)

  • 41. Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies.
    Cavdar H; Senturk M; Guney M; Durdagi S; Kayik G; Supuran CT; Ekinci D
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):429-437. PubMed ID: 30734597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acetylcholinesterase inhibition activity of acetylated depsidones from Lobaria pulmonaria.
    Pejin B; Tommonaro G; Iodice C; Tesevic V; Vajs V
    Nat Prod Res; 2012; 26(17):1634-7. PubMed ID: 21985528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A second site of action of soman on acetylcholinesterase.
    Michaelson S; Gray PJ
    Biochem Pharmacol; 1991 Oct; 42(10):2040-3. PubMed ID: 1741780
    [No Abstract]   [Full Text] [Related]  

  • 44. Cage amines as the stopper inhibitors of cholinesterases.
    Lin G; Tsai HJ; Tsai YH
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2887-90. PubMed ID: 14611850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
    Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
    Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ionic strength dependence of the inhibition of acetylcholinesterase activity by Al3+.
    Sharp TR; Rosenberry TL
    Biophys Chem; 1985 Mar; 21(3-4):261-4. PubMed ID: 3986284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ligands of cholinesterases of ephedrine and pseudoephedrine structure].
    Basova NE; Kormilitsin BN; Perchenok AY; Rozengatt EV; Saakov VS; Suvorov AA
    Zh Evol Biokhim Fiziol; 2013; 49(6):385-93. PubMed ID: 25490843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acetylcholinesterase inhibition by pitofenone: a spasmolytic compound.
    Punekar NS; Kulkarni AV
    Biotechnol Appl Biochem; 1991 Dec; 14(3):378-82. PubMed ID: 1777122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel dynamic flow cytoenzymological determination of intracellular esterase inhibition by BCNU and related isocyanates.
    Dive C; Workman P; Watson JV
    Biochem Pharmacol; 1987 Nov; 36(21):3731-8. PubMed ID: 3675627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malathion as a model for the enzymatic hydrolysis of the neurotoxic agent, VX.
    Hoskin FC; Walker JE
    Bull Environ Contam Toxicol; 1997 Jul; 59(1):9-13. PubMed ID: 9229491
    [No Abstract]   [Full Text] [Related]  

  • 51. Acetylcholinesterase activity of alkaloids from the leaves of Waltheria brachypetala.
    Lima MM; López JA; David JM; Silva EP; Giulietti AM; de Queiroz LP; David JP
    Planta Med; 2009 Mar; 75(4):335-7. PubMed ID: 19101888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of electric eel acetylcholinesterase by porphin compounds.
    Lee BH; Park MB; Yu BS
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1467-70. PubMed ID: 9873371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New acetylcholinesterase inhibitors--derivatives of vitamin B6].
    Karpeĭskiĭ MIa; Padiukova NSh; Varlamov VP; Bannikova GE
    Bioorg Khim; 1994 Oct; 20(10):1132-6. PubMed ID: 7826410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors.
    Kračmarová A; Drtinová L; Pohanka M
    Acta Medica (Hradec Kralove); 2015; 58(2):37-42. PubMed ID: 26455564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Dependence of anti-acetylcholinesterase effectiveness of phosphoorganic inhibitors on the accessibility of the phosphorus atom].
    Shestakova NN; Rozengart EV; Zhorov BS
    Bioorg Khim; 1992 Apr; 18(4):596-603. PubMed ID: 1503573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease.
    Li Y; Zhang XX; Jiang LJ; Yuan L; Cao TT; Li X; Dong L; Li Y; Yin SF
    Chem Biol Drug Des; 2015 Oct; 86(4):776-82. PubMed ID: 25736722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bicarbonate-catalyzed hydrolysis of hexamethylene diisocyanate to 1,6-diaminohexane.
    Berode M; Testa B; Savolainen H
    Toxicol Lett; 1991 Apr; 56(1-2):173-8. PubMed ID: 2017775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of the kinetic constants of inhibited acetyl cholinesterase.
    Tudela J; García Cánovas F; García Carmona F; Lozano JA
    Ital J Biochem; 1986; 35(4):259-65. PubMed ID: 3781806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of salt effects on the reactions of acetylcholinesterase with cationic and anionic inhibitors.
    Tõugu V; Kesvatera T
    Biochim Biophys Acta; 2001 Jan; 1544(1-2):189-95. PubMed ID: 11341928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural insights into substrate traffic and inhibition in acetylcholinesterase.
    Colletier JP; Fournier D; Greenblatt HM; Stojan J; Sussman JL; Zaccai G; Silman I; Weik M
    EMBO J; 2006 Jun; 25(12):2746-56. PubMed ID: 16763558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.